State Street Corp Adamis Pharmaceuticals Corp Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.55 - $0.73 $30,342 - $40,272	55,168 Added 13.13%	475,373 $271,000
Q2 2021 Aug 16, 2021	BUY	$0.66 - $1.23 $247,701 - $461,625	375,305 Added 835.87%	420,205 $462,000
Q1 2021 May 17, 2021	BUY	$0.54 - $1.79 $3,456 - $11,456	6,400 Added 16.62%	44,900 $42,000
Q1 2020 May 11, 2020	BUY	$0.33 - $0.89 $12,705 - $34,265	38,500 New	38,500 $14,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.